News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
July 30, 2026
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
Attachment
2026 Half-year Financial Report_Ipsen S.A.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Psychedelics
Compass to submit psilocybin depression drug for approval imminently after stock wobbles
November 3, 2026
·
2 min read
·
Heather McKenzie
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
November 3, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Pfizer flat in Q3 despite 32% growth for new and acquired products
November 3, 2026
·
2 min read
·
Annalee Armstrong
Earnings
AbbVie’s Q3 beat should keep ‘train rolling’ as company eyes bolt-on deals
October 30, 2026
·
3 min read
·
Gabrielle Masson